PTC Therapeutics Reports Third Quarter 2015 Financial Results, Provides Corporate Update and Reviews Key Findings from ACT DMD
Go back to PTC Therapeutics Reports Third Quarter 2015 Financial Results, Provides Corporate Update and Reviews Key Findings from ACT DMD| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 75.14 +0.43 (0.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $74.71 | 52 Week High | $35.40 | |||
| Open | $74.71 | 52 Week Low | $4.03 | |||
| Day High | $75.93 | P/E | 7.99 | |||
| Day Low | $74.36 | EPS | $9.40 | |||
| Volume | 1,074,600 | |||||
